Biotech

All Articles

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Rehab was actually wowed good enough with Harbour BioMed's bispecific immune reactor that ...

A more detailed examine Brutal Biotech's Tough 15

.In this week's incident of "The Leading Line," we are actually diving in to Strong Biotech's yearly...

Lilly deals with stage 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's celebration celebrating the commenda...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant leadership hirings, firings as we...

Lykos will definitely talk to FDA to reconsider its choice adhering to rejection of MDMA treatment for trauma

.Observing an unsatisfactory revealing for Lykos Rehabs' MDMA prospect for trauma at a recent FDA co...

AN 2 one-halfs census, ceases stage 3 trial after information disappoint

.AN2 Therapies is actually reviewing its own service in response to uninspired midphase information,...

Merck pays out $700M for bispecific, spying autoimmune opening and also odds to test Amgen in cancer

.Merck &amp Co. is paying out $700 thousand beforehand to challenge Amgen in a blood cancer market. ...

Gilead spends J&ampJ $320M to exit licensing deal for seladelpar

.With Gilead Sciences about to an FDA decision for its own liver illness medicine seladelpar, the bu...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can easily find the companies establishing camping tents at bas...

Entero giving up staff, abandoning office and also stopping R&ampD

.Bed Liquidators has actually transformed Entero Therapeutics white as a piece. The collector purcha...